|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/575 | |
| A61K 38/00 |
| (11) | Number of the document | 2330124 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10012149.0 |
| Date of filing the European patent application | 2006-08-11 | |
| (97) | Date of publication of the European application | 2011-06-08 |
| (45) | Date of publication and mention of the grant of the patent | 2015-02-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201664 | 2005-08-11 | US | |
| 206903 | 2005-08-17 | US | |
| 301744 | 2005-12-12 | US |
| (72) |
Levy, Odile Esther, US
Hanley, Michael R., US
Jodka, Carolyn M., US
Lewis, Diana, US
Soares, Christopher J., US
Ghosh, Soumitra S., US
D`Souza, Lawrence, US
Parkes, David G., US
Mack, Christine M., US
Forood, Behrouz Bruce, US
|
| (73) |
Amylin Pharmaceuticals, LLC,
9360 Towne Centre Drive, San Diego, CA 92121,
US
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE, US |
| (54) | Hybrid polypeptides with selectable properties |
| Hybrid polypeptides with selectable properties |